Press Releases

Archive: May 2021


Half yearly report to 31 March 2021

IXICO plc (AIM: IXI), the AI data analytics company delivering insights in neuroscience, announces its unaudited interim results for the six months ended 31 March 2021. Financial highlights: · Reported revenues of £4. 9 million for the six months to 31 March 2021 (H1 2020: £4.

Read more

Phase II Alzheimer’s disease contract award worth >£1m

IXICO plc, the AI data analytics company delivering insights in neuroscience, announces that it has been awarded an expansion contract by a current biopharmaceutical client to support the company’s Phase II Alzheimer’s disease clinical trial.

Read more

Contract win for new neuroinflammatory disorder

Contract extends IXICO’s CNS franchise to include a further new disease indication IXICO plc, the AI data analytics company delivering insights in neuroscience, announces that it has been selected by a current biopharmaceutical client to provide neuroimaging services for a Phase III clinical trial.

Read more